FDA approves Biogen Idec’s multiple sclerosis drug

August 16, 2014 4:18 AM

31 0

FDA approves Biogen Idec’s multiple sclerosis drug

Scrambling to stay ahead of the competition in bringing multiple sclerosis drugs to market, Biogen Idec Inc. won US regulatory approval Friday to sell a new type of injectable drug that treats adults with the most common form of the neurodegenerative disease.

Food and Drug Administration regulators approved the Cambridge biotech’s application to market the drug, called Plegridy, as a longer-lasting treatment for US patients with relapsing-remitting multiple sclerosis. The approval came less than a month after the European Commission approved Biogen Idec’...

Also read: Russian-Bought Ads on Facebook Spur Lawmakers to Call for Tighter Rules

Read more

To category page